| pubmed-article:15788695 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15788695 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:15788695 | lifeskim:mentions | umls-concept:C1332002 | lld:lifeskim |
| pubmed-article:15788695 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
| pubmed-article:15788695 | lifeskim:mentions | umls-concept:C0013203 | lld:lifeskim |
| pubmed-article:15788695 | lifeskim:mentions | umls-concept:C1332710 | lld:lifeskim |
| pubmed-article:15788695 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15788695 | pubmed:dateCreated | 2005-3-24 | lld:pubmed |
| pubmed-article:15788695 | pubmed:abstractText | Acute myeloid leukemia (AML) is considered a stem cell disease. Incomplete chemotherapeutic eradication of leukemic CD34+38- stem cells is likely to result in disease relapse. The purpose of this study was to investigate the role of the breast cancer resistance protein (BCRP/ATP-binding cassette, subfamily G, member 2) in drug resistance of leukemic stem cells and the effect of its modulation on stem cell eradication in AML. | lld:pubmed |
| pubmed-article:15788695 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15788695 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15788695 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15788695 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15788695 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:15788695 | pubmed:author | pubmed-author:ScheperRik... | lld:pubmed |
| pubmed-article:15788695 | pubmed:author | pubmed-author:SchefferGeorg... | lld:pubmed |
| pubmed-article:15788695 | pubmed:author | pubmed-author:RaaijmakersMa... | lld:pubmed |
| pubmed-article:15788695 | pubmed:author | pubmed-author:RaymakersRein... | lld:pubmed |
| pubmed-article:15788695 | pubmed:author | pubmed-author:JansenJoop... | lld:pubmed |
| pubmed-article:15788695 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:15788695 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:15788695 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:15788695 | pubmed:author | pubmed-author:HeuverLeonie... | lld:pubmed |
| pubmed-article:15788695 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15788695 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:15788695 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:15788695 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15788695 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15788695 | pubmed:pagination | 2436-44 | lld:pubmed |
| pubmed-article:15788695 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:meshHeading | pubmed-meshheading:15788695... | lld:pubmed |
| pubmed-article:15788695 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15788695 | pubmed:articleTitle | Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia. | lld:pubmed |
| pubmed-article:15788695 | pubmed:affiliation | Department of Hematology and Central Hematology Laboratory, University Medical Center Nijmegen, St. Radboud, 6500 HB Nijmegen, the Netherlands. h.raajmakers@chl.umcn.nl | lld:pubmed |
| pubmed-article:15788695 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15788695 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15788695 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15788695 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15788695 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15788695 | lld:pubmed |
